These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12527919)

  • 1. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
    Navolanic PM; Steelman LS; McCubrey JA
    Int J Oncol; 2003 Feb; 22(2):237-52. PubMed ID: 12527919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.
    Papadimitriou E; Chatzellis E; Dimitriadi A; Kaltsas GA; Theocharis S; Alexandraki KI
    touchREV Endocrinol; 2023 Nov; 19(2):42-53. PubMed ID: 38187082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity, acute and sub-chronic toxicities of the leaves of Bauhinia thonningii (Schumach.) Milne-Redh. (Caesalpiniaceae).
    Matieta VY; Mbaveng AT; Nouemsi GRS; Tankeo SB; Kamsu GT; Nayim P; Lannang AM; Çelik İ; Efferth T; Kuete V
    BMC Complement Med Ther; 2023 Sep; 23(1):341. PubMed ID: 37752510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Benefits of Epidermal Growth Factor for Inhibiting Muscle Degrative Markers in Rats with Alcoholic Liver Damage.
    Xiao Q; Chen YH; Chen YL; Chien YS; Hsieh LH; Shirakawa H; Yang SC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of the methanol extracts and compounds of Brucea antidysenterica (Simaroubaceae) towards multifactorial drug-resistant human cancer cell lines.
    Youmbi LM; Makong YSD; Mbaveng AT; Tankeo SB; Fotso GW; Ndjakou BL; Wansi JD; Beng VP; Sewald N; Ngadjui BT; Efferth T; Kuete V
    BMC Complement Med Ther; 2023 Feb; 23(1):48. PubMed ID: 36793009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer.
    Alam MS; Sultana A; Sun H; Wu J; Guo F; Li Q; Ren H; Hao Z; Zhang Y; Wang G
    Front Pharmacol; 2022; 13():942126. PubMed ID: 36204232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas.
    Rai A; Das L; Mukherjee KK; Dhandapani S; Tripathi M; Ahuja CK; Radotra BD; Dutta P
    Front Endocrinol (Lausanne); 2021; 12():708111. PubMed ID: 34295309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 Signaling in Breast Cancer.
    Shin I
    Adv Exp Med Biol; 2021; 1187():53-79. PubMed ID: 33983573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing.
    Li L; Deng L; Meng X; Gu C; Meng L; Li K; Zhang X; Meng Y; Xu W; Zhao L; Chen J; Zhu Z; Huang H
    Transl Oncol; 2021 Jan; 14(1):100916. PubMed ID: 33129108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration.
    Wang K; Zhu TN; Zhao RJ
    Mol Med Rep; 2019 Oct; 20(4):3671-3678. PubMed ID: 31485594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
    Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
    Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells
    Albert S; Arndt C; Koristka S; Berndt N; Bergmann R; Feldmann A; Schmitz M; Pietzsch J; Steinbach J; Bachmann M
    Oncotarget; 2018 May; 9(39):25597-25616. PubMed ID: 29876011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine Epidemic Diarrhea Virus-Induced Epidermal Growth Factor Receptor Activation Impairs the Antiviral Activity of Type I Interferon.
    Yang L; Xu J; Guo L; Guo T; Zhang L; Feng L; Chen H; Wang Y
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
    Molavi O; Narimani F; Asiaee F; Sharifi S; Tarhriz V; Shayanfar A; Hejazi M; Lai R
    Pharm Biol; 2017 Dec; 55(1):729-739. PubMed ID: 28027688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paradox role of caspase cascade in ionizing radiation therapy.
    Rahmanian N; Hosseinimehr SJ; Khalaj A
    J Biomed Sci; 2016 Dec; 23(1):88. PubMed ID: 27923354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of actin filaments and suppression of pancreatic cancer cell viability and migration following treatment with polyisoprenylated cysteinyl amides.
    Nkembo AT; Salako O; Poku RA; Amissah F; Ntantie E; Flores-Rozas H; Lamango NS
    Am J Cancer Res; 2016; 6(11):2532-2546. PubMed ID: 27904769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J; Kong J; Chang H; Kim H; Kim A
    Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer.
    Farabaugh SM; Chan BT; Cui X; Dearth RK; Lee AV
    Cell Commun Signal; 2016 Oct; 14(1):25. PubMed ID: 27765041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.
    Chen J; Guo J; Chen Z; Wang J; Liu M; Pang X
    Sci Rep; 2016 Jul; 6():29382. PubMed ID: 27387652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.